158 related articles for article (PubMed ID: 34265804)
1. Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms.
Kolin DL; Konstantinopoulos PA; Campos SM; Toumi G; Kolahi KA; Gars EJ; Howitt BE
Am J Surg Pathol; 2022 Feb; 46(2):169-178. PubMed ID: 34265804
[TBL] [Abstract][Full Text] [Related]
2. A Subset of SMARCB1 (INI-1)-deficient vulvar neoplasms express germ cell markers.
Hammer PM; Kolin DL; Charville GW; McCluggage WG; Howitt BE
Histopathology; 2022 Sep; 81(3):342-351. PubMed ID: 35758187
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
6. Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors.
Zamecnik M; Rychnovsky J; Syrovatka J
Int J Surg Pathol; 2018 May; 26(3):245-249. PubMed ID: 29166820
[TBL] [Abstract][Full Text] [Related]
7. Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient Neoplasms.
Yoshida A; Yoshida H; Yoshida M; Mori T; Kobayashi E; Tanzawa Y; Yasugi T; Kawana K; Ishikawa M; Sugiura H; Maeda D; Fukayama M; Kawai A; Hiraoka N; Motoi T
Am J Surg Pathol; 2015 Aug; 39(8):1102-13. PubMed ID: 26171919
[TBL] [Abstract][Full Text] [Related]
8. Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers.
Mills AM; Jenkins TM; Dibbern ME; Atkins KA; Ring KL
Am J Surg Pathol; 2024 Jul; 48(7):790-802. PubMed ID: 38651612
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options.
Hazir B; Şímșek B; Erdemír A; Gürler F; Yazici O; Kizil Y; Aydíl U
Head Neck Pathol; 2022 Jun; 16(2):596-601. PubMed ID: 34420180
[TBL] [Abstract][Full Text] [Related]
11. Unusual Presentations of Gynecologic Tumors: Extragonadal Yolk Sac Tumor of the Vulva.
Euscher ED
Arch Pathol Lab Med; 2017 Feb; 141(2):293-297. PubMed ID: 27959583
[TBL] [Abstract][Full Text] [Related]
12. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
Espinosa I; D'Angelo E; De Brot L; Prat J
Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent In Situ Hybridization Analysis for 12p Alterations in Sarcomatoid Yolk Sac Tumors.
Idrees MT; Ulbright TM; Epstein JI
Am J Surg Pathol; 2019 Nov; 43(11):1566-1573. PubMed ID: 31478941
[TBL] [Abstract][Full Text] [Related]
14. A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression.
Tajima S; Takahasi Y; Hikoaki M; Goto R
Int J Clin Exp Pathol; 2015; 8(6):7526-32. PubMed ID: 26261664
[TBL] [Abstract][Full Text] [Related]
15. Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Massari F; Mollica V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
Pathol Res Pract; 2023 Jan; 241():154269. PubMed ID: 36502737
[TBL] [Abstract][Full Text] [Related]
16. Primary yolk sac (endodermal sinus) tumour of the vulva: a case report.
Subrahmanya NB; Kapadi SN; Junaid TA
Med Princ Pract; 2011; 20(1):90-2. PubMed ID: 21160222
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
Gupta S; Albertson D; Gaston D; Heilbrun ME; Agarwal N; Boucher K; Parnell TJ; Liu T; Morgans A; Madison R; Gowen K; Miller VA; Ross JS; Ali SM; Millis SZ
Clin Genitourin Cancer; 2018 Apr; 16(2):e373-e382. PubMed ID: 28974397
[TBL] [Abstract][Full Text] [Related]
20. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]